These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28641590)

  • 1. Measles elimination and immunisation: national surveillance trends in Japan, 2008-2015.
    Inaida S; Matsuno S; Kobune F
    Epidemiol Infect; 2017 Aug; 145(11):2374-2381. PubMed ID: 28641590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles outbreak investigation in Guji zone of Oromia Region, Ethiopia.
    Belda K; Tegegne AA; Mersha AM; Bayenessagne MG; Hussein I; Bezabeh B
    Pan Afr Med J; 2017; 27(Suppl 2):9. PubMed ID: 28983397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards elimination of measles in Kenya, 2003-2016.
    Kisangau N; Sergon K; Ibrahim Y; Yonga F; Langat D; Nzunza R; Borus P; Galgalo T; Lowther SA
    Pan Afr Med J; 2018; 31():65. PubMed ID: 31007812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress towards measles elimination in Singapore.
    Ho HJ; Low C; Ang LW; Cutter JL; Tay J; Chan KP; Ooi PL; Thoon KC; Goh KT
    Vaccine; 2014 Dec; 32(51):6927-6933. PubMed ID: 25444818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current situation of measles in Japan, 2017].
    Tanaka-Taya K
    Uirusu; 2017; 67(1):17-24. PubMed ID: 29593147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving measles elimination and emerging modified measles: Longitudinal measles epidemiology from 1982 to 2021 in Osaka Prefecture, Japan.
    Kurata T; Kaida Y; Kanbayashi D; Motomura K
    Vaccine; 2024 Jan; 42(2):271-286. PubMed ID: 38097458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    Sowe A; Njie M; Sowe D; Fofana S; Ceesay L; Camara Y; Tesfaye B; Bah S; Bah AK; Baldeh AK; Dampha BD; Baldeh SN; Touray A
    PLoS One; 2021; 16(10):e0258961. PubMed ID: 34673828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards measles elimination in Eritrea: 2003 - 2018.
    Yehdego T; Yhdego TK; Masresha B; Gebreslassie A; Katsande R; Fussum D; Lebo E; Namboze J
    Pan Afr Med J; 2020; 35(Suppl 1):7. PubMed ID: 32373258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles sero-surveillance during mass immunisation campaign in Malawi.
    Takechi M; Matsuo M; Butao D; Zungu IL; Chakanika I; Michongwe J
    East Afr Med J; 2001 Jan; 78(1):4-8. PubMed ID: 11320764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-lasting measles epidemic in Maroua, Cameroon 2008-2009: mass vaccination as response to the epidemic.
    Luquero FJ; Pham-Orsetti H; Cummings DA; Ngaunji PE; Nimpa M; Fermon F; Ngoe N; Sosler S; Strebel P; Grais RF
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S243-51. PubMed ID: 21666169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward measles elimination—Philippines, 1998-2014.
    Takashima Y; Schluter WW; Mariano KM; Diorditsa S; de Quiroz Castro M; Ou AC; Ducusin MJ; Garcia LC; Elfa DC; Dabbagh A; Rota P; Goodson JL;
    MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(13):357-62. PubMed ID: 25856257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 60-year review on the changing epidemiology of measles in capital Beijing, China, 1951-2011.
    Li J; Lu L; Pang X; Sun M; Ma R; Liu D; Wu J
    BMC Public Health; 2013 Oct; 13():986. PubMed ID: 24143899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward measles elimination--Japan, 1999-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1049-52. PubMed ID: 18818586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination.
    Funk S; Knapp JK; Lebo E; Reef SE; Dabbagh AJ; Kretsinger K; Jit M; Edmunds WJ; Strebel PM
    BMC Med; 2019 Sep; 17(1):180. PubMed ID: 31551070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress Toward Regional Measles Elimination - Worldwide, 2000-2016.
    Dabbagh A; Patel MK; Dumolard L; Gacic-Dobo M; Mulders MN; Okwo-Bele JM; Kretsinger K; Papania MJ; Rota PA; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2017 Oct; 66(42):1148-1153. PubMed ID: 29073125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern China.
    Yang Z; Xu J; Wang M; Di B; Tan H; He Q; Cai Y; Liang J; Hu W; Dong Z; Yang Y; Fu C
    Hum Vaccin Immunother; 2014; 10(4):1091-6. PubMed ID: 24513504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.